Search This Blog

Saturday, July 6, 2019

Mixed shelf filing roundup – healthcare

The following healthcare companies have filed prospectuses for mixed shelf offerings:
Translate Bio (NASDAQ:TBIO): $250M.
Cellular Biomedicine Group (NASDAQ:CBMG): $200M.
Iterum Therapeutics (NASDAQ:ITRM): $150M.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)